{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:37:58Z","timestamp":1770507478220,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf02114894","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T23:38:07Z","timestamp":1126654687000},"page":"391-399","source":"Crossref","is-referenced-by-count":26,"title":["Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents againstHelicobacter pylori"],"prefix":"10.1007","volume":"14","author":[{"given":"M.","family":"Nakao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tsuchimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Uekata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02114894_CR1","first-page":"1273","volume":"i","author":"JR Warren","year":"1983","unstructured":"Warren JR, Marshall BJ: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, i: 1273\u20131275.","journal-title":"Lancet"},{"key":"BF02114894_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0016-5085(87)91028-6","volume":"93","author":"MJ Blaser","year":"1987","unstructured":"Blaser MJ: GastricCampylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987, 93: 371\u2013383.","journal-title":"Gastroenterology"},{"key":"BF02114894_CR3","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","volume":"ii","author":"BJ Marshall","year":"1988","unstructured":"Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow CR: Prospective double-blind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 1988, ii: 1437\u20131442.","journal-title":"Lancet"},{"key":"BF02114894_CR4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/17.3.309","volume":"17","author":"CS Goodwin","year":"1986","unstructured":"Goodwin CS, Blake P, Blincow E: The minimum inhibitory and bactericidal concentrations of antibiotics and antiulcer agents againstCampylobacter pyloridis. Journal of Antimicrobial Chemotherapy 1986, 17: 309\u2013314.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02114894_CR5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF01962617","volume":"7","author":"CAM McNulty","year":"1988","unstructured":"McNulty CAM, Dent JC: Susceptibility of clinical isolates ofCampylobacter pylori to twenty-one antimicrobial agents. European Journal of Clinical Microbiology & Infectious Diseases 1988, 7: 566\u2013569.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF02114894_CR6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/AAC.33.9.1650","volume":"33","author":"JA Garcia-Rodriguez","year":"1989","unstructured":"Garcia-Rodriguez JA, Garcia-Sanchez JE, Garcia-Garcia MI, Garcia-Sanchez E, Munoz-Bellido JL: In vitro activities of new oral \u03b2-lactams and macrolides againstCampylobacter pylori. Antimicrobial Agents and Chemotherapy 1989, 33: 1650\u20131651.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/BF01964274","volume":"9","author":"TU Westblom","year":"1990","unstructured":"Westblom TU, Gudipati S, Midkiff BR: In vitro susceptibility ofHelicobacter pylori to the new oral cephalosporins, cefpodoxime, ceftibuten and cefixime. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 691\u2013693.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF02114894_CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0934-8840(11)80966-7","volume":"280","author":"G Recklinghausen von","year":"1993","unstructured":"von Recklinghausen G, Maio CD, Ansorg R: Activity of antibiotics and azole antimycotics againstHelicobacter pylori. Zentralblatt f\u00fcr Bakteriologie 1993, 280: 279\u2013285.","journal-title":"Zentralblatt f\u00fcr Bakteriologie"},{"key":"BF02114894_CR9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF01964416","volume":"10","author":"S Suerbaum","year":"1991","unstructured":"Suerbaum S, Leying H, Klemm K, Opferkuch W: Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1991, 10: 92\u201393.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF02114894_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1099\/00222615-24-4-343","volume":"24","author":"JA Armstrong","year":"1987","unstructured":"Armstrong JA, Wee SH, Goodwin CS, Wilson DH: Response ofCampylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro \u2014 an ultrastructural study. Journal of Medical Microbiology 1987, 24: 343\u2013350.","journal-title":"Journal of Medical Microbiology"},{"key":"BF02114894_CR11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/22.5.631","volume":"22","author":"DJ Hardy","year":"1988","unstructured":"Hardy DJ, Hanson CW, Hensey DM, Beyer JM, Fernandes PB: Susceptibility ofCampylobacter pylori to macrolides and fluoroquinolones. Journal of Antimicrobial Chemotherapy 1988, 22: 631\u2013636.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02114894_CR12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/AAC.30.3.510","volume":"30","author":"T Lambert","year":"1986","unstructured":"Lambert T, Megraud F, Gerbaud G, Couvalin P: Susceptibility ofCampylobacter pyloridis to 20 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1986, 30: 510\u2013511.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/AAC.28.6.837","volume":"28","author":"CAM McNulty","year":"1985","unstructured":"McNulty CAM, Dent J, Wise R: Susceptibility of clinical isolates ofCampylobacter pyloridis to 11 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1985, 28: 837\u2013838.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/AAC.31.6.949","volume":"31","author":"DL Shungu","year":"1987","unstructured":"Shungu DL, Nalin DR, Gilman RH, Gadebusch HH, Cerami AT, Gill C, Weissberger B: Comparative susceptibilities ofCampylobacter pylori to norfloxacin and other agents. Antimicrobial Agents and Chemotherapy 1987, 31: 949\u2013950.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/AAC.33.1.108","volume":"33","author":"AE Simor","year":"1989","unstructured":"Simor AE, Ferro S, Low DE: Comparative in vitro activities of six new fluoroquinolone and other oral antimicrobial agents againstCampylobacter pylori. Antimicrobial Agents and Chemotherapy 1989, 33: 108\u2013109.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/AAC.35.3.490","volume":"35","author":"T Iwahi","year":"1991","unstructured":"Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity againstHelicobacter pylori. Antimicrobial Agents and Chemotherapy 1991, 35: 490\u2013496.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1746.1991.tb01452.x","volume":"6","author":"ATR Axon","year":"1991","unstructured":"Axon ATR:Helicobacter pylori therapy: effect on peptic ulcer disease. Journal of Gastroenterology and Hepatology 1991, 6: 131\u2013137.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"BF02114894_CR18","first-page":"402","volume-title":"Manual of clinical microbiology","author":"JL Penner","year":"1991","unstructured":"Penner JL:Campylobacter, Helicobacter, and related spiral bacteria. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1991, p. 402\u2013409."},{"key":"BF02114894_CR19","first-page":"537","volume-title":"Antibiotics in laboratory medicine","author":"DJ Krogstad","year":"1986","unstructured":"Krogstad DJ, Moellering RC: Antimicrobial combinations. In: Lorian V (ed): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, 1986, p. 537\u2013595."},{"key":"BF02114894_CR20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gut.30.8.1058","volume":"30","author":"CAM McNulty","year":"1989","unstructured":"McNulty CAM, Dent JC, Uff JS, Gear MWL, Wilkinson SP: Detection ofCampylobacter pylori by the biopsy urease test: an assessment in 1445 patients. Gut 1989, 30: 1058\u20131062.","journal-title":"Gut"},{"key":"BF02114894_CR21","first-page":"1486","volume":"337","author":"CA Lingwood","year":"1991","unstructured":"Lingwood CA, Law H, Pellizani A: Gastric glycerolipid as a receptor forCampylobacter pylori. Lancet 1991, 337: 1486.","journal-title":"Lancet"},{"key":"BF02114894_CR22","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/0140-6736(91)93181-8","volume":"337","author":"F Megraud","year":"1991","unstructured":"Megraud F, Boyanova L, Lamouliatte H: Activity of lansoprazole againstHelicobacter pylori. Lancet 1991, 337: 1486.","journal-title":"Lancet"},{"key":"BF02114894_CR23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/infdis\/153.4.658","volume":"153","author":"SL Hazell","year":"1986","unstructured":"Hazell SL, Lee A, Brady L, Hennessy W:Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. Journal of Infectious Diseases 1986, 153: 658\u2013663.","journal-title":"Journal of Infectious Diseases"},{"key":"BF02114894_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1099\/00222615-37-2-123","volume":"37","author":"KA Eaton","year":"1992","unstructured":"Eaton KA, Morgan DR, Krakowka S: Motility as a factor in the colonization of gnotobiotic piglets byHelicobacter pylori. Journal of Medical Microbiology 1992, 37: 123\u2013127.","journal-title":"Journal of Medical Microbiology"},{"key":"BF02114894_CR25","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/IAI.60.6.2470-2474.1992","volume":"60","author":"CA Lingwood","year":"1992","unstructured":"Lingwood CA, Huesca M, Kuksis A: The glycerolipid receptor forHelicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infection and Immunity 1992, 60: 2470\u20132474.","journal-title":"Infection and Immunity"},{"key":"BF02114894_CR26","first-page":"511","volume":"84","author":"M Casselli","year":"1989","unstructured":"Casselli M, Figura N, Trevisani L, Pazzi P, Guglielmetti, P: Patterns of physical modes of contact betweenCampylobacter pylori and gastric epithelium: implications about the bacterial pathogenicity. American Journal of Gastroenterology 1989, 84: 511\u2013513.","journal-title":"American Journal of Gastroenterology"},{"key":"BF02114894_CR27","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/IAI.60.9.3658-3663.1992","volume":"60","author":"GI P\u00e9rez-P\u00e9rez","year":"1992","unstructured":"P\u00e9rez-P\u00e9rez GI, Olivares AZ, Cover TL, Blaser MJ: Characteristics ofHelicobacter pylori variants selected for urease deficiency. Infection and Immunity 1992, 60: 3658\u20133663.","journal-title":"Infection and Immunity"},{"key":"BF02114894_CR28","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/IAI.59.7.2470-2475.1991","volume":"59","author":"KA Eaton","year":"1991","unstructured":"Eaton KA, Brooks CL, Morgan DR, Krakowka S: Essential role of urease in pathogenesis of gastritis induced byHelicobacter pylori in gnotobiotic piglet. Infection and Immunity 1991, 59: 2470\u20132475.","journal-title":"Infection and Immunity"},{"key":"BF02114894_CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(89)90569-2","volume":"ii","author":"P Mainguet","year":"1989","unstructured":"Mainguet P, Delmee M, Debongnie JC: Omeprazole,Campylobacter pylori, and duodenal ulcer. Lancet 1989, ii: 389\u2013390.","journal-title":"Lancet"},{"key":"BF02114894_CR30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(89)92021-7","volume":"ii","author":"G Biasco","year":"1989","unstructured":"Biasco G, Miglioli M, Barbara L, Corinaldesi R, Febo GD: Omeprazole,Helicobacter pylori, gastritis, and duodenal ulcer. Lancet 1989, ii: 1403.","journal-title":"Lancet"},{"key":"BF02114894_CR31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01297022","volume":"36","author":"WM Hui","year":"1991","unstructured":"Hui WM, Lam SK, Ho J, Lai CL, Lok ASF, Lau WY, Branicki FJ: Effect of omeprazole on duodenal ulcer-associated antral gastritis andHelicobacter pylori. Digestive Diseases and Sciences 1991, 36: 577\u2013582.","journal-title":"Digestive Diseases and Sciences"},{"issue":"196","key":"BF02114894_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365529309098336","volume":"28","author":"P Unge","year":"1993","unstructured":"Unge P, Ekstr\u00f6m P: Effect of combination therapy with omeprazole and an antibiotic onHelicobacter pylori and duodenal ulcer disease. Scandinavian Journal of Gastroenterology 1993, 28, Supplement 196: 17\u201318.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"BF02114894_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0140-6736(92)90502-T","volume":"340","author":"RPH Logan","year":"1992","unstructured":"Logan RPH, Gummett PA, Hegarty BT, Walker MM, Baron JH, Misiewicz JJ: Clarithromycin and omeprazole forHelicobacter pylori. Lancet 1992, 340: 239.","journal-title":"Lancet"},{"key":"BF02114894_CR34","first-page":"697","volume":"4","author":"E Bayerd\u00f6rffer","year":"1992","unstructured":"Bayerd\u00f6rffer E, Mannes GA, Sommer A, H\u00f6chter W, Weingart J, Hatz R, Lehn N, Ruckdeschel G, Dirschedl P, Stolte M: High dose omeprazole treatment combined with amoxicillin eradicatesHelicobacter pylori. European Journal of Gastroenterology & Hepatology 1992, 4: 697\u2013702.","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"BF02114894_CR35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/gut.34.9.1167","volume":"34","author":"J Labenz","year":"1993","unstructured":"Labenz J, Gyenes E, R\u00fchl GH, B\u00f6rsch G: Amoxicillin plus omeprazole versus triple therapy for eradication ofHelicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. Gut 1993, 34: 1167\u20131170.","journal-title":"Gut"},{"key":"BF02114894_CR36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/bmj.293.6548.645","volume":"293","author":"CAM McNulty","year":"1986","unstructured":"McNulty CAM, Gearty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R:Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. British Medical Journal 1986, 293: 645\u2013649.","journal-title":"British Medical Journal"},{"key":"BF02114894_CR37","first-page":"70","volume":"Supplement 53","author":"P Unge","year":"1988","unstructured":"Unge P, Gnarpe H: Pharmacokinetic, bacteriological and clinical aspects of the use of doxycycline in patients with active duodenal ulcer associated withCampylobacter pylori. Scandinavian Journal of Infectious Diseases 1988, Supplement 53: 70\u201373.","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF02114894_CR38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(87)90527-7","volume":"i","author":"Y Glupczynski","year":"1987","unstructured":"Glupczynski Y, Labbe M, Burette A, Delmee M, Avesani V, Bruck C: Treatment failure of ofloxacin inCampylobacter pylori infection. Lancet 1987, i: 1096.","journal-title":"Lancet"},{"key":"BF02114894_CR39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jac\/22.1.92","volume":"22","author":"JW Stone","year":"1988","unstructured":"Stone JW, Wise R, Donovan IA, Gearty J: Failure of ciprofloxacin to eradicateCampylobacter pylori from the stomach. Journal of Antimicrobial Chemotherapy 1988, 22: 92\u201393.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02114894_CR40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.33.2.256","volume":"33","author":"JCC Mertens","year":"1989","unstructured":"Mertens JCC, Dekker W, Ligtvoet EEJ, Blok P: Treatment failure of norfloxacin againstCampylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia. Antimicrobial Agents and Chemotherapy 1989, 33: 256\u2013257.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02114894_CR41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0016-5085(92)90095-G","volume":"102","author":"DY Graham","year":"1992","unstructured":"Graham DY, Lew GM, Malaty HM, Evans DJ, Klein PD, Alpert LC, Genta RM: Factors influencing the eradication ofHelicobacter pylori with triple therapy. Gastroenterology 1992, 102: 493\u2013496.","journal-title":"Gastroenterology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02114894.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02114894\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02114894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T12:09:32Z","timestamp":1586434172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02114894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF02114894"],"URL":"https:\/\/doi.org\/10.1007\/bf02114894","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}